• Home
  • News
  • Arts & Culture
  • Sports
  • Opinion
  • Media
    • Cartoons
    • Galleries
    • Podcasts
    • Videos
✕

Supreme Court Hears Abortion Drug Arguments

Published by Lydia Schoessling on April 9, 2024

Graphic by Rachel Fratt

A lawsuit regarding a drug that medically induces abortion appeared in front of the Supreme Court on March 26.

The legal organization “Alliance Defending Freedom” filed the case against the U.S. Food and Drug Administration, alleging the FDA neglected to consider serious safety issues when allowing medical abortions to be easier to obtain. The ADF is the same organization that played a significant role in overturning Roe V. Wade in 2022. 

The FDA has rejected these claims, and many leading major medical organizations, such as the American Medical Association, have agreed that the drug is safe.

A medical abortion involves two pills: mifepristone and misoprostol. Mifepristone is the first drug administered, which prevents the hormone ‘progesterone’ from being able to help develop the pregnancy. The second drug administered is misoprostol, which expels the pregnancy from the uterus. 

The case only centers around mifepristone, a hormone blocker, failing to address the drug that induces the termination. 

The ADF initially filed its case in November 2022 in Amarillo, Texas, where it was brought before a federal judge, Matthew Kacsmaryk, who ruled in favor of the ADF’s claims. 

In May 2023, the Biden Administration took the ruling to New Orleans, La., where the Fifth Circuit Court of Appeals heard arguments on the federal government’s appeal, and the court issued its decision a few months later in August. That decision stated that mifepristone should be available, but the method in which patients can access the drug should go back to what was in place before the FDA began making changes in 2016. 

In the aftermath of the Fifth Circuit Court of Appeals’ ruling, the Biden Administration asked the Supreme Court to consider the challenges against mifepristone. As the Supreme Court evaluates its decision, the previous rulings are all temporarily blocked. The decision is likely to be released around the early summer. 

But what would either ruling mean? If the court rules in favor of the FDA, the Supreme Court will overturn the previous rulings, and mifepristone will remain on the market as before the lawsuit. If the court rules in favor of the ADF, it would overturn the FDA’s 2000 approval of mifepristone. 

 

Related posts

Photo by Venezia Munoz

May 6, 2025

EU Business Students Hit the Books


Read more
May 6, 2025

21 Proposed Anti-LGBTQ Bills in Illinois: A Significant Increase From Last Year’s Numbers


Read more

Photo by Lydia Schoessling

May 6, 2025

Legislation Targeting Abortion in Illinois: An Attack on a Sanctuary State


Read more

About Us

Our Mission

Advertising

Letter to the Editor

Frequently Asked Questions

Contact Us

Categories

News

Arts & Culture

Sports

Opinion

Social Media

Twitter

Facebook

YouTube

Spotify

Media Hub

Cartoons

Galleries

Podcasts

Videos

© 2025 The Leader. All Rights Reserved.